Asensus Surgical, Inc. Stock

Equities

ASXC

US04367G1031

Medical Equipment, Supplies & Distribution

Market Closed - Nyse 04:00:00 2024-04-17 pm EDT 5-day change 1st Jan Change
0.26 USD -0.38% Intraday chart for Asensus Surgical, Inc. -5.42% -18.47%
Sales 2024 * 12.3M Sales 2025 * 22.21M Capitalization 70.72M
Net income 2024 * -62M Net income 2025 * -55M EV / Sales 2024 * 5.75 x
Net cash position 2024 * - Net cash position 2025 * - EV / Sales 2025 * 3.18 x
P/E ratio 2024 *
-1.41 x
P/E ratio 2025 *
-1.79 x
Employees 208
Yield 2024 *
-
Yield 2025 *
-
Free-Float 98.03%
More Fundamentals * Assessed data
Dynamic Chart
1 day-0.38%
1 week-5.42%
Current month+13.04%
1 month-7.14%
3 months-11.56%
6 months+2.36%
Current year-18.47%
More quotes
1 week
0.25
Extreme 0.25
0.28
1 month
0.21
Extreme 0.208
0.30
Current year
0.21
Extreme 0.208
0.38
1 year
0.20
Extreme 0.204
0.86
3 years
0.20
Extreme 0.204
3.75
5 years
0.20
Extreme 0.204
27.69
10 years
0.20
Extreme 0.204
90.74
More quotes
Managers TitleAgeSince
Chief Executive Officer 52 15-07-31
Director of Finance/CFO 57 20-08-23
Chief Tech/Sci/R&D Officer - -
Members of the board TitleAgeSince
Director/Board Member 68 04-12-31
Director/Board Member 59 21-07-21
Founder 70 98-08-18
More insiders
Date Price Change Volume
24-04-17 0.26 -0.38% 1,391,261
24-04-16 0.261 -5.09% 1,823,986
24-04-15 0.275 +1.48% 1,640,174
24-04-12 0.271 -2.55% 1,349,126
24-04-11 0.2781 +1.16% 1,756,519

Delayed Quote Nyse, April 17, 2024 at 04:00 pm EDT

More quotes
Asensus Surgical, Inc. is a medical device company digitizing the interface between the surgeon and patient to reimagine surgery through Performance-Guided Surgery to enable surgeons to deliver outcomes to patients and establish a new standard of surgery. It operates in one business segment, which is the research, development and sale of medical device robotics to improve minimally invasive surgery. It is developing the LUNA Surgical System, a robotic and instrument system as a foundation of its Digital Surgery solution. These systems shall be powered by the Intelligent Surgical Unit to enhance surgeon control and reduce surgical variability. With the addition of machine vision, Augmented Intelligence, and deep learning capabilities throughout the surgical experience, it intends to holistically address the clinical, cognitive and economic shortcomings that drive surgical outcomes and value-based healthcare. It is also working to incorporate all of this in the LUNA Surgical System.
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
C-
More Ratings
Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
2
Last Close Price
0.26 USD
Average target price
0.35 USD
Spread / Average Target
+34.62%
Consensus